SUMMARY
Evidence accrued over the last decade has supported an association between low serum selenium (Se) and
increased incidence of prostate cancer in older men. Accordingly, questions and inquiry arose as to whether a
dietary supplementation might afford protection, or delay disease progression. Indeed, a very large national
study, Selenium and Vitamin E Cancer Prevention Trial (SELECT), to explore the potential benefits of a
daily supplement of 200 microgram Se, or 400 I.U. of vitamin E, or both, is underway: the National Cancer
Institute anticipates a total enrolment of 32,400 men and durations of 7 to 12 years for individual participants.
It is remarkable that at the time of the trial's activation in 2001 nothing was known about the concentration of
Se in the target organ or whether any Se in a dietary supplement found its way to the prostate gland. Later,
our laboratory published the first benchmark values, which indicated that the prostate is reasonably well
endowed with Se and that the concentration in one subject, who had undergone self-medication at 200
microgram Se per day, was about twice the average for the others. This review explores the ramifications of
these and subsequent data for SELECT and other trials, together with observations on dose and general
mechanisms of Se interference with the development of prostate cancer.
KEY WORDS
selenium; prostate; cancer; supplementation trials
REFERENCES
Aaseth J, Smith-Kielland A, Thomassen Y:
Selenium, alcohol and liver diseases. Ann Clin
Res 18:43-47, 1986.
Arnold WN, Thrasher JB: Selenium
concentration in the prostate. Biol Trace El
Res 91:277-280, 2003.
Arthur JR, Nicol F, Grant E, Beckett GJ: The
effects of selenium deficiency on hepatic type-I
iodothyronine deiodinase and protein
disulphide-isomerase assessed by activity
measurements and affinity labeling. Biochem J
274:297-300, 1991.
Barry MJ: Clinical practice. Prostate-specific-antigen
testing for early diagnosis of prostate
cancer. N Engl J Med 344:1373-1377, 2001.
Beck MA: Rapid genomic evolution of a non-virulent
coxsackievirus B3 in selenium-deficient
mice. Biomed Environ Sci 10:307-315, 1997.
Beck MA, Kolbeck PC, Shi Q et al.: Increased
virulence of a human enterovirus
(coxsackievirus B3) in selenium-deficient mice.
J Infect Dis 170:351-357, 1994.
Beck MA, Shi Q, Morris VC, Levander OA:
Rapid genomic evolution of a non-virulent
coxsackievirus B3 in selenium-deficient mice
results in selection of identical virulent isolates.
Nat Med 1:433-436, 1995.
Brooks JD, Metter EJ, Chan DW et al.: Plasma
selenium level before diagnosis and the risk of
prostate cancer development. J Urol
166:2034-2038, 2001.
Clark LC, Cantor KP, Allaway WH: Selenium
in forage crops and cancer mortality in U.S.
counties. Arch Environ Health 46:37-42, 1991.
Clark LC, Combs Jr. GF, Turnbull BW et al.:
Effects of selenium supplementation for cancer
prevention in patients with carcinoma of the
skin. A randomized controlled trial. Nutritional
Prevention of Cancer Study Group. JAMA.
276:1957-1963, 1996.
Clark LC, Dalkin B, Krongrad A et al.:
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind
cancer prevention trial. Br J Urol
81:730-734, 1998.
Duffield-Lillico AJ, Dalkin BL, Reid ME et al.:
Selenium supplementation, baseline plasma
selenium status and incidence of prostate
cancer: an analysis of the complete treatment
period of the Nutritional Prevention of Cancer
Trial. BJU Int 91:608-612, 2003.
Epp O, Ladenstein R, Wendel A: The refined
structure of the selenoenzyme glutathione
peroxidase at 0.2 nm resolution. Eur J
Biochem 133:51-69, 1983.
Ge K, Yang G: The epidemiology of selenium
deficiency in the etiological study of endemic
diseases in China. Am J Clin Nutr 57:259-263, 1993.
Gianduzzo TR, Holmes EG, Tinggi U et al.:
Prostatic and peripheral blood selenium levels
after oral supplementation. J Urol 170:870-873, 2003.
Gohagan JK, Prorok PC, Kramer BS, Cornett
JE: Prostate cancer screening in the prostate,
lung, colorectal and ovarian cancer screening
trial of the National Cancer Institute. J Urol
152:1905-1909, 1994.
Guilbert LJ, Iscoe NN: Partial replacement of
serum by selenite, transferrin, albumin and
lecithin in haemopoietic cell cultures. Nature
263:594-595, 1976.
Hartman TJ, Taylor PR, Alfthan G et al.:
Toenail selenium concentration and lung cancer
in male smokers (Finland). Cancer Causes
Control 13:923-928, 2002.
Hill KE, McCollum GW, Boeglin ME, Burk
RF: Thioredoxin reductase activity is
decreased by selenium deficiency. Biochem
Biophys Res Commun 234:293-295, 1997.
Holmberg L, Bill-Axelson A, Helgesen F et al.: A
randomized trial comparing radical
prostatectomy with watchful waiting in early
prostate cancer. N Engl J Med 347:781-789, 2002.
Hoque A, Albanes D, Lippman SM et al.:
Molecular epidemiologic studies within the
Selenium and Vitamin E Cancer Prevention
Trial (SELECT). Cancer Causes Control
12:627-633, 2001.
Jensen R, Closson W, Rothenberg R:
Epidemiologic notes and reports: selenium
intoxication New York. MMWR CDC
Surveill Summ 33:157-158, 1984. [see also,
JAMA 251:1938, 1984.]
Kim SP, Bennett CL, Chan C et al.: QOL and
outcomes research in prostate cancer patients
with low socioeconomic status. Oncology
(Huntingt.) 13:823-832, 1999.
Klein EA, Thompson IM, Lippman SM et al.:
SELECT: The selenium and vitamin E cancer
prevention trial: rationale and design. Prostate
Cancer Prostatic Dis 3:145-151, 2000.
Levander OA: Metabolic interrelationships and
adaptations in selenium toxicity. Ann NY
Acad Sci 192:181-192, 1972.
Levander OA: A global view of human selenium
nutrition. Annu Rev Nutr 7:227-250, 1987.
Levander OA, Alfthan G, Arvilommi H et al.:
Bioavailability of selenium to Finnish men as
assessed by platelet glutathione peroxidase
activity and other blood parameters. Am J
Clin Nutr 37:887-897, 1983.
Lombeck I, Kasperek K, Feinendegen LE,
Bremer HJ: Serum-selenium concentrations in
patients with maple-syrup-urine disease and
phenylketonuria under diet-therapy. Clin Chim
Acta 64:57-61, 1975.
Lyon TD, Fell GS, Halls DJ, Clark J,
McKenna F: Determination of nine inorganic
elements in human autopsy tissue. J Trace
Elem Electrolytes Health Dis 3:109-118, 1989.
McKeehan WL, Hamilton WG, Ham RG:
Selenium is an essential trace nutrient for
growth of WI-38 diploid human fibroblasts.
Proc Natl Acad Sci USA 73:2023-2027, 1976.
Medinsky MA, Cuddihy RG, Griffith WC,
McClellan RO: A stimulation model
describing the metabolism of inhaled and
ingested selenium compounds. Toxicol Appl
Pharmacol 59:54-63, 1981.
Moreno-Reyes R, Suetens C, Mathieu F et al.:
Kashin-Beck osteoarthropathy in rural Tibet in
relation to selenium and iodine status. N Engl
J Med 339:1112-1120, 1998.
Moyad MA: Selenium and vitamin E supplements
for prostate cancer: evidence or embellishment?
Urology 59 (4, suppl. 1):9-19, 2002.
Patterson EL, Milstrey R, Stokstad ELR: Effect
of selenium in preventing exudative diathesis in
chicks. Proc Soc Exptl Biol Med 95:617-620, 1957.
Pohl B, Schneider T: Determination of Normal
Levels of Selenium in Blood Serum by
GFAAS. Varian Optical Spectroscopy
Instruments, Instruments at work, AA-103,
August 1991.
Raich PC, Lu J, Thompson HJ, Combs GF:
Selenium in cancer prevention: clinical issues
and implications. Cancer Invest 19:540-553, 2001.
Rotruck JT, Pope AL, Ganther HE et al.:
Selenium: biochemical role as a component of
glutathione peroxidase. Science 179:588-590, 1973.
Salonen JT, Huttunen JK: Selenium in
cardiovascular diseases. Ann Clin Res 18:30-35, 1986.
Schaller KH, Schiele R: Selenium. In Alessio L,
Berlin A, Roi R (eds): Biological Indicators
for the Assessment of Human Exposure to
Industrial Chemicals, Comm Eur Commun
Luxembourg 1989, pp. 77-93.
Schwarz K, Foltz CM: Selenium as an integral
part of Factor 3 against dietary necrotic liver
degeneration. J Amer Chem Soc.71:3292-3293,1957.
Schwarz K, Bieri JG, Briggs GM, Scott ML:
Prevention of exudative diathesis in chicks by
Factor 3 and selenium. Proc Soc Exptl Biol
Med 95:621-625, 1957.
Shamberger RJ, Frost DV: Possible protective
effect of selenium against human cancer. Can
Med Assoc J 104:82-84, 1968.
Sheehan TMT, Halls DJ: Measurement of
selenium in clinical specimens. Ann Clin
Biochem 36:301-315, 1999.
Stadtman TC: Specific occurrence of selenium in
enzymes and amino acid tRNAs. Faseb J
1:375-379, 1987.
Stadtman TC: Biosynthesis and function of
selenocysteine-containing enzymes. J Biol
Chem 266:16257-16260, 1992.
Stratton MS, Reid ME, Schwartzberg G et al.:
Selenium and prevention of prostate cancer in
high-risk men: the Negative Biopsy Study.
Anticancer Drugs 14:589-594, 2003a.
Stratton MS, Reid ME, Schwartzberg G et al.:
Selenium and inhibition of disease progression
in men diagnosed with prostate carcinoma:
study design and baseline characteristics of the
'Watchful Waiting' Study. Anticancer Drugs
14:595-600, 2003b.
Sunde RA: Selenium. In O'Dell BL and Sunde RA (eds): Handbook of Nutritionally
Essential Minerals, Marcel Dekker, New York
1997, pp. 493-556.
Thompson IM, Pauler DK, Goodman PJ et al.:
Prevalence of prostate cancer among men with
a prostate-specific antigen level < or = 4.0 ng
per milliliter. N Engl J Med 350:2239-2246, 2004.
Vanderpas JB, Contempre B, Duale NL et al.:
Iodine and selenium deficiency associated with
cretinism in northern Zaire. Am J Clin Nutr
52:1087-1093, 1990.
Willett WC, Polk BF, Morris JS et al.:
Prediagnostic serum selenium and risk of
cancer. Lancet 2:130-134, 1983.
Wilt TJ, Brawer MK: The prostate cancer
intervention versus observation trial: a
randomized trial comparing radical
prostatectomy versus expectant management for
the treatment of clinically localized prostate
cancer. J Urol 152:1903-1904, 1994.
Yang G, Zhou R: Further observations on the
human maximum safe dietary selenium intake
in a seleniferous area of China. J Trace Elem
Electrolytes Health Dis 8:159-165, 1994.
Yang G, Wang S, Zhou R, Sun S: Endemic
selenium intoxication of humans in China. Am
J Clin Nutr 37:872-881, 1983.
Yoshizawa K, Willett WC, Morris SJ et al.:
Study of prediagnostic selenium level in
toenails and the risk of advanced prostate
cancer. J Natl Cancer Inst 90:1219-1224, 1998.
|
CITED
Zaichick S, Zaichick V. Trace elements of normal, benign hypertrophic and cancerous tissues of the Human prostate gland investigated by neutron activation analysis. Appl Radiat Isot. 70: 81-87, 2012.
Gupta UC, Gupta SC. Selenium deficiency in soils and crops and its impact on animal and human health. Curr Nutr Food Sci. 6: 268-280, 2010.
|
